Cielito Reyes-Gibby

12PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 17, 2024
Severity of Symptoms as an Independent Predictor of Poor Outcomes in Patients with Advanced Cancer Presenting to the Emergency Department: Secondary Analysis of a Prospective Randomized Study.

Aiham Qdaisat, Elizabeth Stroh, Cielito Reyes-Gibby

|Aug 29, 2024
Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review.

Demis N Lipe, Aiham Qdaisat, Pavitra P Krishnamani

|May 10, 2024
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi).

Cielito C Reyes-Gibby, Jeffrey M Caterino, Christopher J Coyne

|Dec 28, 2023
Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors.

Cielito C Reyes-Gibby, Aiham Qdaisat, Renata Ferrarotto

|Dec 09, 2023
Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.

Erin Marie D San Valentin, Kim-Anh Do, Sai-Ching J Yeung

|Sep 09, 2023
Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.

Liangliang Zhang, Erin Marie D San Valentin, Teny M John

Pageof 2

Frequent Collaborators

3 joint publications

Aiham Qdaisat

3 joint publications

Sai-Ching J Yeung

3 joint publications

Sanjay Shete

2 joint publications

Renata Ferrarotto